ENHANCED STIMULATION BY RIBAVIRIN OF THE 5'-PHOSPHORYLATION AND ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY OF PURINE 2'-BETA-FLUORO-2',3'-DIDEOXYNUCLEOSIDES

被引:0
|
作者
JOHNS, DG
AHLUWALIA, GS
COONEY, DA
MITSUYA, H
DRISCOLL, JS
机构
[1] NCI,DIV CANC TREATMENT,BETHESDA,MD 20892
[2] NCI,CLIN ONCOL PROGRAM,MED BRANCH,EXPTL RETROVIROL SECT,BETHESDA,MD 20892
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purine dideoxynucleosides 2'-beta-fluoro-2',3'-dideoxyadenosine (2'-beta-F-ddAdo), 2'-beta-fluoro-2',3'-dideoxyinosine, and 2'-beta-fluoro-2',3'-dideoxyguanosine (2'-beta-F-ddGuo) are active inhibitors of the replication of the human immunodeficiency virus (HIV) in the ATH8 assay system, with 2'-beta-F-ddAdo and 2'-beta-fluoro-2',3'-dideoxyinosine showing activity and potency equivalent to those of their respective parent compounds, 2',3'-dideoxyadenosine (ddAdo) and 2',3'-dideoxyinosine. Because inhibitors of IMP dehydrogenase such as ribavirin and tiazofurin stimulate the 5'-phosphorylation and consequently the anti-HIV activity of the three nonfluorinated parent compounds (ddAdo, 2',3'-dideoxyinosine, and 2',3'-dideoxyguanosine), we have undertaken a study in MOLT-4 cells to determine whether a similar stimulatory effect is observed with their 2'-beta-fluorinated analogs. The 5'-phosphorylation of all the fluoro compounds was found to be greatly enhanced by low levels (10 muM) of either ribavirin or tiazofurin, with the greatest increase being seen with 2'-beta-F-ddAdo, where stimulation of the formation of the 5'-mono-, di-, and triphosphorylated nucleotides was approximately 20-fold, 6-fold, and 5-fold, respectively. These increases were approximately 3-fold greater than the increases seen with the nonfluorinated parent compound ddAdo. In the case of 2'-beta-F-ddGuo, the greatest stimulation (8-fold) was seen in the formation of the 5'-diphosphate. In parallel with the increased phosphorylation of 2'-beta-F-ddAdo and 2'-beta-F-ddGuo, the anti-HIV potency of these two compounds at the 5 mum level was approximately doubled in the presence of ribavirin (5 muM).
引用
收藏
页码:519 / 523
页数:5
相关论文
共 50 条
  • [41] EFFECT OF ANTI-HIV 2'-BETA-FLUORO-2',3'-DIDEOXYNUCLEOSIDE ANALOGS ON THE CELLULAR CONTENT OF MITOCHONDRIAL-DNA AND ON LACTATE PRODUCTION
    TSAI, CH
    DOONG, SL
    JOHNS, DG
    DRISCOLL, JS
    CHENG, YC
    BIOCHEMICAL PHARMACOLOGY, 1994, 48 (07) : 1477 - 1481
  • [42] DETERMINATION OF THE ANTI-HIV DRUG 2'-BETA-FLUORO-2',3'-DIDEOXYADENOSINE IN BIOLOGICAL-FLUIDS BY REVERSED-PHASE HPLC
    ROTH, JS
    KELLEY, JA
    JOURNAL OF LIQUID CHROMATOGRAPHY, 1995, 18 (03): : 441 - 462
  • [43] INVITRO INHIBITION OF THE INFECTIVITY AND REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS BY COMBINATIONS OF ANTI-RETROVIRAL 2', 3'-DIDEOXYNUCLEOSIDES AND VIRAL BINDING INHIBITORS
    HAYASHI, S
    MITSUYA, H
    BRODER, S
    CLINICAL RESEARCH, 1989, 37 (02): : A411 - A411
  • [44] ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY OF THE NOVEL ANTIVIRAL ANTIBIOTIC QUARTROMICINS WHICH ENHANCE INHIBITORY EFFECT OF 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE (AZT) INVITRO
    TANABETOCHIKURA, A
    NAKASHIMA, H
    MURAKAMI, T
    TENMYO, O
    OKI, T
    YAMAMOTO, N
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1992, 3 (06) : 345 - 349
  • [45] INHIBITORY EFFECT OF 2',3'-DIDEHYDRO-2',3'-DIDEOXYNUCLEOSIDES ON INFECTIVITY, CYTOPATHIC EFFECTS, AND REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS
    HAMAMOTO, Y
    NAKASHIMA, H
    MATSUI, T
    MATSUDA, A
    UEDA, T
    YAMAMOTO, N
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (06) : 907 - 910
  • [46] 5-AMINO DERIVATIVES OF 2',3'-DIDEOXYNUCLEOSIDES FOR EVALUATION OF ANTI-HIV ACTIVITY
    ABDELMEGIED, AES
    PEDERSEN, H
    PEDERSEN, EB
    NIELSEN, C
    HETEROCYCLES, 1993, 36 (04) : 681 - 690
  • [47] OPTIMIZATION OF POLY(MALEIC ACID-ALT-ACYCLOHEXYL-1,3-DIOXEPIN-5-ENE) FOR ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY
    DING, JL
    OTTENBRITE, RM
    POLYMERIC DRUGS AND DRUG ADMINISTRATION, 1994, 545 : 135 - 148
  • [48] 5'-O-PHOSPHONOMETHYL-2',3'-DIDEOXYNUCLEOSIDES - SYNTHESIS AND ANTI-HIV ACTIVITY
    JIE, L
    VANAERSCHOT, A
    BALZARINI, J
    JANSSEN, G
    BUSSON, R
    HOOGMARTENS, J
    DECLERCQ, E
    HERDEWIJN, P
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) : 2481 - 2487
  • [49] SYNERGISTIC ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EFFECT OF HYDROXAMATE COMPOUNDS WITH 2',3'-DIDEOXYINOSINE IN INFECTED RESTING HUMAN-LYMPHOCYTES
    MALLEY, SD
    GRANGE, JM
    HAMEDISANGSARI, F
    VILA, JR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) : 11017 - 11021
  • [50] NOVEL 3'-SUBSTITUTED PURINE 2', 3'-DIDEOXYNUCLEOSIDE ANALOGS AS INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS
    BALZARINI, J
    BABA, M
    PAUWELS, R
    HERDEWIJN, P
    ROBINS, MJ
    WOOD, SG
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1988, 96 (01): : B5 - B5